8月8日,锦欣生殖(01951)发布公告,预计本集团将在截至2025年6月30日的上半年录得亏损不超过10.9亿元,而在截至2024年6月30日的上半年则录得纯利约1.9亿元。此次亏损主要由于对本集团在美国及老挝业务的若干商誉、无形资产及其他金融资产确认减值及拨备。公司已仔细评估运营及财务表现以及未来前景,实际减值及拨备金额仍待进一步评估。
此外,公告还提到,公司董事会宣布委任执行董事兼首席执行官董阳为公司的代理首席财务官。董阳将负责监督本集团的财务管理、业务发展及运营等相关职务。截止公告日期,董阳持有本公司1010万股股份的权益,包括根据公司股份计划获授的342万股股份。
(文章来源:财中社)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.